|
Mr. Lawlor is a General Partner with HealthCare Ventures LLC. Prior to joining Health Care Ventures in 2000 Mr. Lawlor served as Chief Operating Officer of LeukoSite from 1997 to 2000. Before joining LeukoSite Mr. Lawlor served as Chief Financial Officer and Vice President of Corporate Development of Alpha-Beta Technology. He was previously Chief Financial Officer and Vice President Business Development of BioSurface Technology. Mr. Lawlor serves on the Board of Directors of a number of private companies including: Aton Pharma Inc.; Dynogen Pharma Inc.; GlobeImmune Inc.; NuVios Inc.; Replidyne Inc.; Upstate Group Inc.; U.S. Genomics Inc.; VaxInnate Corp.; and the Slater Center for Biomedical Technology. He received a B.A. degree from the University of New Hampshire where he was elected to Phi Beta Kappa and received a master’s degree in management from Yale University. | 